-
Who we are
Who we are
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Discover our scienceLearn about our validated protein-based nanoparticle and Matrix-M™ adjuvant technology.
-
What we do
What we do
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
Do you have the experience and expertise in becoming a clinical trial site?
Novavax is a biotechnology company committed to helping to address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
Do you have the experience and expertise to participate as a clinical trial site to develop transformational vaccines that help address some of the world’s most pressing infectious diseases?
All fields marked with asterisk (*) are required.